









Markets
/
Stocks
/
nasdaq-tfx
/

Teleflex Inc

TFX

107.970USD

-1.430-1.31%

Close 11/10, 16:00（ET）Quotes delayed by 15 min

4.77BMarket Cap

LossP/E TTM



Teleflex Inc

107.970

-1.430-1.31%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Teleflex Inc

Currency: USD Updated: 2025-11-10

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Teleflex Inc's Score

Industry at a Glance

Industry Ranking

45 / 209

Overall Ranking

125 / 4611

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 14 analysts

Hold

Current Rating

133.579

Target Price

+22.10%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Teleflex Inc Highlights

StrengthsRisks

Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 90.56%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 90.56%.

Undervalued

The company’s latest PE is -15.04, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 47.10M shares, decreasing 10.12% quarter-over-quarter.

Held by Louis Moore Bacon

Star Investor Louis Moore Bacon holds 106.23K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-10

The company's current financial score is 8.51, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 913.02M, representing a year-over-year increase of 19.45%, while its net profit experienced a year-over-year increase of 468.36%.

Score

Industry at a Glance

Previous score

8.51

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.61

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.11

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.64

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.18

Key Metrics

Free cash flow

No Data

Teleflex Inc's Company Valuation

Currency: USD Updated: 2025-11-10

The company’s current valuation score is 7.50, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -15.04, which is -920.72% below the recent high of 123.46 and -1.32% above the recent low of -15.24.

Score

Industry at a Glance

Previous score

7.50

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 45/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-10

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Teleflex Inc is 122.00, with a high of 198.21 and a low of 114.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 14 analysts

Hold

Current Rating

133.579

Target Price

+22.10%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Teleflex Inc

TFX

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-10

The company’s current price momentum score is 6.70, which is lower than the Healthcare Equipment & Supplies industry's average of 7.00. Sideways: Currently, the stock price is trading between the resistance level at 128.43 and the support level at 95.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.76

Change

-0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-4.979

Sell

RSI(14)

27.428

Sell

STOCH(KDJ)(9,3,3)

21.496

Neutral

ATR(14)

4.563

High Vlolatility

CCI(14)

-160.512

Sell

Williams %R

83.853

Oversold

TRIX(12,20)

-0.206

Sell

StochRSI(14)

3.208

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

115.008

Sell

MA10

120.590

Sell

MA20

124.743

Sell

MA50

125.256

Sell

MA100

122.123

Sell

MA200

131.128

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-10

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 106.58%, representing a quarter-over-quarter decrease of 3.23%. The largest institutional shareholder is The Vanguard, holding a total of 4.78M shares, representing 10.81% of shares outstanding, with 9.11% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

5.94M

-4.38%

BlackRock Institutional Trust Company, N.A.

4.97M

-7.19%

The Vanguard Group, Inc.

Star Investors

4.80M

-5.32%

Janus Henderson Investors

4.15M

-4.08%

Atlanta Capital Management Company, L.L.C.

2.40M

-13.46%

UBS Financial Services, Inc.

1.47M

-55.70%

State Street Investment Management (US)

1.46M

-4.52%

Dimensional Fund Advisors, L.P.

1.24M

+43.09%

Cooke & Bieler, L.P.

1.21M

+14.04%

Geode Capital Management, L.L.C.

987.65K

-3.09%

Risk Assessment

Currency: USD Updated: 2025-11-10

The company’s current risk assessment score is 8.01, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.97. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.